PRESS-RELEASE ·Filed Apr 21, 2026
Press release: earnings
Actionable Insight • Neutral
Schedule to monitor the May 5 earnings call for updates on MYQORZO commercial performance and pipeline progress; absence of material data in this release suggests no pre-announcement surprise.
Final — all horizons settled through T+60d
CYTK ▲ +21.03% at T+60d
NEUTRAL call ✓ call won +21.03% · α vs SPY +16.25% · entry $66.25 → $80.18
T+1d
-1.16%
call -1.16% · α -0.77%
$65.48
settled 5mo ago
T+5d
-10.84%
call -10.84% · α -10.89%
$59.07
settled 5mo ago
T+20d
+15.40%
call +15.40% · α +12.23%
$76.45
settled 5mo ago
T+60d
+21.03%
call +21.03% · α +16.25%
$80.18
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Cytokinetics announced a scheduled date for its Q1 2026 earnings release on May 5, 2026, with a subsequent conference call. No financial results were reported in this press release — it is purely administrative.
Key Facts
- Cytokinetics will report Q1 2026 financial results on May 5, 2026 at 4:00 PM ET
- Management will host a conference call at 4:30 PM ET to discuss results and provide updates
- No actual financial data was released in this announcement
- Recent insider activity shows $1.2M in insider sales over the past 30 days
Financial Impact
No financial impact from this filing — results not yet reported
Risk Factors
- Potential for downward guidance or weak revenue trends in upcoming earnings
- Insider selling activity may signal reduced confidence ahead of results
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3278393 |
32 reports for CYTK
89% Hit rate best @ T+20▲ +10.38%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $69.31 $67.59 | ▲ +2.48% | ▲ +4.59% | $65.60 (+5.35%) |
Sep 11, 2026 20d ago | Insider Cluster | $72.45 $67.56 | ▼ −6.75% | ▼ −6.86% | $65.60 (−9.45%) |
Sep 1, 2026 4w ago | Insider Cluster | $71.40 $74.11 | ▲ +3.80% | ▲ +3.71% | $65.60 (−8.12%) |
Aug 31, 2026 4w ago | Insider Cluster | $71.40 $74.11 | ▲ +3.80% | ▲ +3.71% | $65.60 (−8.12%) |
Aug 29, 2026 4w ago | Press Release | $70.91 $75.35 | ▲ +6.26% | ▲ +6.40% | $65.60 (−7.49%) |
Aug 28, 2026 5w ago | 8-K | $72.09 $72.72 | ▲ +0.87% | ▲ +0.76% | $65.60 (−9.00%) |
Jul 30, 2026 9w ago | Insider Cluster | $80.42 $81.37 | ▲ +1.18% | ▼ −2.44% | $65.60 (−18.43%) |
Jul 27, 2026 9w ago | Insider Cluster | $80.62 $77.13 | ▼ −4.33% | ▼ −5.40% | $65.60 (−18.63%) |
Jul 23, 2026 10w ago | Press Release | $80.74 $80.42 | ▼ −0.40% | ▼ −0.77% | $65.60 (−18.75%) |
Jul 14, 2026 11w ago | Insider Cluster | $81.93 $79.11 | ▼ −3.44% | ▼ −2.15% | $65.60 (−19.93%) |
Showing 10 of 32
US Market Status
Market Closed — Opens Mon (65h 4m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access